An Agreement to Accelerate Product Placement and Insertion of the Numobag(TM) Kit, a Medical Device for First Responder, DHS/State Staffs, and Military Services Dealing with Battlefield Wounds or Bioterrorism Incident, Was Announced Today.

NORTHRIDGE, Calif. -- Numotech, Inc. today announced that it has signed an agreement with SRS Technologies, a national engineering and technology market leader to facilitate product sales, placement and insertion within the Department of Defense ("DOD"), the Department of Homeland Security ("DHS"), the National Guard in various states as well as key state and local agencies with Numotech's flagship product, the Numobag(TM), a disposable, lightweight, wound-healing device used to deliver Topical Hyperbaric Oxygen Therapy (THOT(TM)).

The Numobag(TM) is an ideal, rapid-response isolation unit for treating DoD personnel with serious battlefield wounds as well as chemical, radiological or biologically induced wounds in the event of a terrorist attack. Our homeland security vigilance and preparatory roles have heightened as a result of the 9/11 incident in New York and the anthrax scare in Washington DC. DOD employees, civilians, and military dependents at home and around the world are potential targets. The number of potential users are significant within the US and around the world. The Numobag(TM) is currently used by the military and has been accepted by the Department of Homeland Security as a cost-effective first responder medical device in its strategic protection arsenal.

Dr. Robert Felton, President of Numotech, Inc., noted that "This strategic relationship combines the vast engineering, technology, and service capabilities of SRS Technologies with the efficacy of our Numobag(TM) product, greatly enhancing our ability to support key relationships with the DOD and DHS. There are over 2.6M `first responders' in this country who are America's first line of defense in any terrorist attack, including local police, firefighters, and emergency medical professionals. Properly trained and equipped first responders with the Numobag(TM) kit by SRS will have the greatest potential to save lives, limit casualties, and effectively deal with the aftermath of a terrorist attack."

About Numotech, Inc.

Numotech, Inc. is a premier wound-care company headquartered in Northridge, CA. Numotech specializes in the research, design, manufacture and marketing of wound-care treatment and prevention products for advanced-stage wounds. Numotech is known for its highly advanced R&D efforts in collaboration with Sandia National Laboratories. This access to one of the world's premier engineering facilities has resulted in the cost-effective development of quality-engineered products through the commercial adaptation of highly advanced defense-related technology that is revolutionizing wound-care management and treatment. The resulting medical devices are proven first-responder applications for bioterrorism, homeland defense, and on military battlefields. For more information, please contact www.numotech.com.

About SRS Technologies

SRS Technologies, since its founding in 1970, has become a highly diversified advanced engineering and technology corporation providing business services and products to a wide array of Government and Commercial customers on a worldwide basis. With three and a half decades of experience, SRS is an established technology and systems engineering company offering skills, experience and technical knowledge to our customer base. The goals of SRS are to provide the very best services in System Engineering, System Integration and Information Technologies and to foster continuous innovation and performance improvement to our customer base. For more information, please contact www.srs.com.